HIV Treatments in Development

Latent Tendencies: New Strategies Target Dormant HIV

    Block-and-Lock Strategy for HIV-1 Cure
    A schematic diagram of the approach under development by Susana Valente and colleagues at the Scripps Research Institute in Florida. A drug called a Tat inhibitor is being employed to try and permanently prevent latent HIV from being able to reactivate and produce new viruses (a state they describe as "deep latency").

    Richard Jefferys

    Positively Aware

    Positively Aware


    Positively Aware, published by Test Positive Aware Network in Chicago, provides accurate, up-to-date treatment information for people living with HIV and their caregivers.